Welcome to our new website. We have rebranded from Atnahs to Pharmanovia — read more
Basildon (UK), 10 November 2021 – Pharmanovia, the original medicines specialist globally, today announced that its leadership team will be presenting at the Jefferies London Healthcare Conference on Tuesday, November 16th, 2021 at 10:00 a.m. GMT.
Dr James Burt (CEO) and Felipe Florez (CFO), together with the founder of Pharmanovia, Dr Amit Patel, will provide an overview on the company’s global activities, its growth development to date as well as an update on the company’s financials and growth strategy going forward.
The leadership team will also host live 1×1 meetings during November 16th and 17th and also during Jefferies Virtual Healthcare Conference, taking place November 18th and 19th, 2021.
Interested registered parties may access the live webcast via: https://wsw.com/webcast/jeff201/pharman/2285154
About Pharmanovia – The original medicines specialist globally
Pharmanovia is a fast-growing pharmaceutical company with a portfolio of over 20 brands across 140+ markets. Our focus is on delivering high-quality branded prescription medicines to patients, prescribers, and healthcare providers across the globe. Our purpose is to reinvigorate and innovate iconic medicines for the benefit of patient health globally. We aspire to be an agile and imaginative specialty pharma business and a preferred partner for innovator pharma companies.
Our therapeutic areas include Cardiovascular, Women’s Health & Endocrinology, Neurology & Pain and Gastroenterology and Oncology.
For further information: pharmanovia.com
Pharmanovia Press Contact
Kate Antonopoulos, Corporate Marketing & Communications Manager
Phone: +44 1268 943857